Plasma protein fraction (human) is a plasma protein solution used to treat coagulation factor deficiencies, reverse anticoagulant effects, and shock from a loss of plasma fluids, and is also used in plasma exchange procedures. The plasma protein fraction human (PPFh) is defined as a sterile solution of proteins composed mainly of albumin and globulin derived from human plasma.
- Mechanism
- Curator reviewed · 1 reference
PPFh acts by replacing the missing blood plasma factor in the patient. It is important to highlight that as a part of the manufacturing process, PPFh has to be completely virus inactivated.
- Primary indication
- PPFh is used as a replacement therapy in patients with complex deficiencies of coagulation factors such as coagulopathy.Curator reviewed · 15 structured indications
- First approval
- Canada, 2011 · United States, 2013
- Also known as
- Human plasma protein · Human plasma protein fraction · Human plasma proteins · Plasma protein fraction · Plasma protein fraction human
Resolves to
What you can answer from here — as of July 07, 2026
Which drugs share a target with Plasma protein fraction (human), and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account